How is the Oculis Holding AG today?

The Oculis Holding AG today is trading in the down by -0.26% at 19.45.

What is Oculis Holding AG Annual Net Profit?

Oculis Holding AG Annual Net Profit rose 3.41% in the last year to $85.78 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Oculis Holding AG Price to Earning Ratio?

Oculis Holding AG Price to Earning Ratio is -8.09, which is negative.

What is Oculis Holding AG Stock Price?

Oculis Holding AG Stock Price rose 65.39% and outperformed its sector by 9.92% in the past year.

What is Oculis Holding AG Quarterly Net profit?

Oculis Holding AG Quarterly Net profit fell 106.38% YoY to $33.21 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Oculis Holding AG Debt to Equity Ratio?

Oculis Holding AG Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Oculis Holding AG Return on Equity(ROE)?

Oculis Holding AG Return on Equity(ROE) for the last financial year was -102.66%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Oculis Holding AG Mutual Fund Holding?

Oculis Holding AG Mutual Fund Holding increased by 1.57% in the last quarter to 3.47.

What is Oculis Holding AG Interest Coverage Ratio?

Oculis Holding AG Interest Coverage Ratio is -133.49, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Oculis Holding AG Institutional Holding?

Oculis Holding AG Institutional Holding increased by 2.68% in the last quarter to 8.57.

Oculis Holding AG XNAS: OCS

Oculis Holding AG Live Share Price Today, Share Analysis and Chart

Name: Oculis Holding AG: Is Infosys Ltd. worth buying?
Item: Oculis Holding AG
Rating: 1.62625
Author: Trendlyne DVM scores

about

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease...

19.45 -0.05 (-0.26%)

80.26% Gain from 52W Low

39,563 XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

2.0 / 100

Technically Moderately Bullish

63.1 / 100

No estimates available

Oculis Holding AG Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Oculis Holding AG FAQ

How is Oculis Holding AG today?

Oculis Holding AG today is trading in the red, and is down by -0.26% at 19.45.

How has Oculis Holding AG performed historically?

Oculis Holding AG is currently trading down -0.26% on an intraday basis. In the past week the stock rose 2.31%. stock has been down -0.66% in the past quarter and rose 65.39% in the past year. You can view this in the overview section.